Related Experiment Videos

[Dosage forms in the therapy of cardiovascular and circulatory diseases]

J M Bultmann1, S Schweiger

  • 1IPMB, Abt. Pharmazeutische Technologie und Pharmakologie der Universität Heidelberg. bultmann@uni-hd.de

Therapeutische Umschau. Revue Therapeutique
|July 18, 2006
PubMed

Insights

This guide details cardiovascular drug dosage forms, including rare ones. It covers application specifics, crushing/dividing guidelines for instant-release formulations, and safe drug substitution strategies.

Area of Science:

  • Pharmacology
  • Pharmaceutical Technology

Context:

  • Cardiovascular and circulatory diseases require precise medication management.
  • Understanding diverse dosage forms is crucial for effective treatment.

Purpose:

  • To provide a comprehensive overview of cardiovascular drug dosage forms.
  • To detail application considerations, including crushing and substitution.
  • To offer guidance on safe administration of cardiovascular medications.

Summary:

  • Presents a collection of current and rare dosage forms for cardiovascular diseases.
  • Lists critical application details based on individual dosage form properties.
  • Includes general recommendations, information on dividing/crushing (instant-release vs. modified-release), and safe drug substitution prerequisites.

Impact:

  • Enhances safe and effective use of cardiovascular medications.
  • Supports healthcare professionals in optimizing drug administration.
  • Aids in informed decision-making regarding drug formulation and substitution.

Related Concept Videos

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Oral Drug Delivery Systems: Introduction01:23

Oral Drug Delivery Systems: Introduction

Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...